Therapy News and Research

RSS

OXGENE launches a scalable, plasmid-free manufacturing system for AAV

OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV.

From OXGENE 23 Sep 2020

UEA researchers put virtual reality rehabilitation for stroke survivors to the test

Researchers at the University of East Anglia have been putting virtual reality rehabilitation for stroke survivors to the test.

23 Sep 2020

Light therapy is safe and can benefit patients with TBI, shows study

Light therapy is safe and has measurable effects in the brain, according to a pioneering study by researchers from the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH).

23 Sep 2020

Study examines the mental health of adolescents before and after the pandemic lockdown

The COVID-19 crisis has taken a psychological toll on people of all ages, but one group especially affected is teenagers. School closures and enforced social distancing have cut off many teens from major means of psychological support, putting them at higher risk of developing anxiety and depression.

23 Sep 2020

Intra-CREATE grants awarded to support research on personalized medicine and cell therapy

Researchers from Critical Analytics for Manufacturing Personalized-Medicine, an interdisciplinary research group at Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have been awarded Intra-CREATE grants from the National Research Foundation Singapore to help support research on retinal biometrics for glaucoma progression and neural cell implantation therapy for spinal cord injuries.

22 Sep 2020

NIH expands clinical trials to evaluate convalescent plasma as a treatment for COVID-19

Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19.

22 Sep 2020

Research consortium receives $111 million NCI grant to prevent, treat HIV-related cancers

The widespread use of antiretroviral therapy to suppress the HIV virus has helped tens of millions of people with HIV live healthier, longer lives--but an unfortunate consequence of people living longer with HIV is an increased risk of cancer.

22 Sep 2020

Sotorasib phase 1 trial shows encouraging anti-cancer activity in lung, colorectal cancers

A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorectal cancers, reports a new study led by City of Hope and other renowned comprehensive cancer centers.

22 Sep 2020

Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

Capecitabine is a chemotherapy drug used for breast and colorectal Cancer cancer. It can extend survival rate by nearly 10%.

21 Sep 2020

Targeted therapy improves disease-free survival in patients with early-stage NSCLC

According to updated findings led by researchers at Yale Cancer Center, treatment with the targeted therapy osimertinib following surgery continues to significantly improve disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) gene mutations.

21 Sep 2020

Oncology nurses should be routinely tested for SARS-CoV-2, warn researchers

Researchers from the NHS Foundation Trust, University of Cambridge and Cambridge Clinical Laboratories have warned that until a vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) becomes available, antigen and antibody testing should be carried out among oncology nurses as part of routine patient care.

21 Sep 2020

Biomarker for earlier diagnosis of neurodegenerative diseases detected in the eye

A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves as a marker for earlier diagnosis of neurodegenerative diseases is now detectable in the eye.

21 Sep 2020

Immunotherapy benefits patients with gastric and esophageal cancers, new data shows

New data presented at ESMO 2020 have shown that immunotherapy is beneficial for patients with gastric and esophageal cancers who currently have poor survival.

21 Sep 2020

Research uncovers potential cause of neurotoxicity due to immunotherapy

New research has uncovered the previously unknown presence of CD19 -- a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma -- in brain cells that protect the blood brain barrier (BBB).

21 Sep 2020

Researchers generate accurate replications of human retinas in a dish

Scientists have generated accurate replications of human retinas in culture that can be used to pinpoint the specific types of cells affected by genetic eye diseases.

21 Sep 2020

Study highlights the need for new strategies to treat patients with treatment-resistant depression

Clinical trials happen in a highly controlled setting and while they are extremely useful in gathering robust information about drugs and how they work, there are many more variables that might affect how a drug works in a real-life setting outside of clinical trials e.g. different patient populations and environments.

21 Sep 2020

Researchers identify a compound that inhibits growth of schwannomas

Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

21 Sep 2020

Therapy News and Research

OXGENE launches a scalable, plasmid-free manufacturing system for AAV

UEA researchers put virtual reality rehabilitation for stroke survivors to the test

Light therapy is safe and can benefit patients with TBI, shows study

Study examines the mental health of adolescents before and after the pandemic lockdown

Intra-CREATE grants awarded to support research on personalized medicine and cell therapy

NIH expands clinical trials to evaluate convalescent plasma as a treatment for COVID-19

Research consortium receives $111 million NCI grant to prevent, treat HIV-related cancers

Sotorasib phase 1 trial shows encouraging anti-cancer activity in lung, colorectal cancers

Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

Targeted therapy improves disease-free survival in patients with early-stage NSCLC

Oncology nurses should be routinely tested for SARS-CoV-2, warn researchers

Biomarker for earlier diagnosis of neurodegenerative diseases detected in the eye

Immunotherapy benefits patients with gastric and esophageal cancers, new data shows

Research uncovers potential cause of neurotoxicity due to immunotherapy

Researchers generate accurate replications of human retinas in a dish

Study highlights the need for new strategies to treat patients with treatment-resistant depression

Researchers identify a compound that inhibits growth of schwannomas

Providing personalized care for bleeding disorders

Providing personalized care for bleeding disorders

Awareness of erectile dysfunction is alarmingly low in men and women

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News